相关实验视频

Updated: Sep 10, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

在头部和部,头骨底部和大脑瘤的成年人中进行前性评估的下垂体功能障碍

Jordan Bouter1, Nathan Azemar2, Anthony Vela1

  • 1Department of Radiotherapy, Centre François Baclesse. 4 Av General Harris, 14000, Caen, France.

Scientific reports
|August 24, 2025
PubMed
概括

大脑瘤的放射治疗通常会导致脑下垂体激素缺乏. 这项研究发现37. 1%的患者在两年内出现新的缺陷,突出显示了在放射治疗后需要标准化的内分泌监测.

关键词:
大脑内分泌系统头部和部低垂体症放射治疗一个瘤

更多相关视频

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition11:45

Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition

Published on: November 14, 2013

12.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321